These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 27722125)

  • 1. Radiation-induced immune responses: mechanisms and therapeutic perspectives.
    Jeong H; Bok S; Hong BJ; Choi HS; Ahn GO
    Blood Res; 2016 Sep; 51(3):157-163. PubMed ID: 27722125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rationale for Combining Radiotherapy and Immune Checkpoint Inhibition for Patients With Hypoxic Tumors.
    Eckert F; Zwirner K; Boeke S; Thorwarth D; Zips D; Huber SM
    Front Immunol; 2019; 10():407. PubMed ID: 30930892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor Microenvironment as A "Game Changer" in Cancer Radiotherapy.
    Jarosz-Biej M; Smolarczyk R; Cichoń T; Kułach N
    Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31261963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypofractionated Irradiation Has Immune Stimulatory Potential and Induces a Timely Restricted Infiltration of Immune Cells in Colon Cancer Tumors.
    Frey B; Rückert M; Weber J; Mayr X; Derer A; Lotter M; Bert C; Rödel F; Fietkau R; Gaipl US
    Front Immunol; 2017; 8():231. PubMed ID: 28337197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SMAC Mimetic Debio 1143 and Ablative Radiation Therapy Synergize to Enhance Antitumor Immunity against Lung Cancer.
    Tao Z; McCall NS; Wiedemann N; Vuagniaux G; Yuan Z; Lu B
    Clin Cancer Res; 2019 Feb; 25(3):1113-1124. PubMed ID: 30352911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor hypoxia and reoxygenation: the yin and yang for radiotherapy.
    Hong BJ; Kim J; Jeong H; Bok S; Kim YE; Ahn GO
    Radiat Oncol J; 2016 Dec; 34(4):239-249. PubMed ID: 28030900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myeloid-derived suppressor cells: Roles in the tumor microenvironment and tumor radiotherapy.
    Yin Z; Li C; Wang J; Xue L
    Int J Cancer; 2019 Mar; 144(5):933-946. PubMed ID: 29992569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloid suppressor cells in cancer and autoimmunity.
    Sica A; Massarotti M
    J Autoimmun; 2017 Dec; 85():117-125. PubMed ID: 28728794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overcoming barriers to effective immunotherapy: MDSCs, TAMs, and Tregs as mediators of the immunosuppressive microenvironment in head and neck cancer.
    Davis RJ; Van Waes C; Allen CT
    Oral Oncol; 2016 Jul; 58():59-70. PubMed ID: 27215705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune-modulating properties of ionizing radiation: rationale for the treatment of cancer by combination radiotherapy and immune checkpoint inhibitors.
    Derer A; Frey B; Fietkau R; Gaipl US
    Cancer Immunol Immunother; 2016 Jul; 65(7):779-86. PubMed ID: 26590829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Approaches to Improve the Efficacy of Immuno-Radiotherapy.
    Shevtsov M; Sato H; Multhoff G; Shibata A
    Front Oncol; 2019; 9():156. PubMed ID: 30941308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypofractionated Irradiation Suppressed the Off-Target Mouse Hepatocarcinoma Growth by Inhibiting Myeloid-Derived Suppressor Cell-Mediated Immune Suppression.
    Chen J; Wang Z; Ding Y; Huang F; Huang W; Lan R; Chen R; Wu B; Fu L; Yang Y; Liu J; Hong J; Zhang W; Zhang L
    Front Oncol; 2020; 10():4. PubMed ID: 32117702
    [No Abstract]   [Full Text] [Related]  

  • 13. Building immunity to cancer with radiation therapy.
    Haikerwal SJ; Hagekyriakou J; MacManus M; Martin OA; Haynes NM
    Cancer Lett; 2015 Nov; 368(2):198-208. PubMed ID: 25592036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological Mechanisms Responsible for Radiation-Induced Abscopal Effect.
    Rodríguez-Ruiz ME; Vanpouille-Box C; Melero I; Formenti SC; Demaria S
    Trends Immunol; 2018 Aug; 39(8):644-655. PubMed ID: 30001871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
    Lunsford LD; Flickinger JC; Larson D
    Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In situ vaccination by radiotherapy to improve responses to anti-CTLA-4 treatment.
    Vanpouille-Box C; Pilones KA; Wennerberg E; Formenti SC; Demaria S
    Vaccine; 2015 Dec; 33(51):7415-7422. PubMed ID: 26148880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The irradiated tumor microenvironment: role of tumor-associated macrophages in vascular recovery.
    Russell JS; Brown JM
    Front Physiol; 2013; 4():157. PubMed ID: 23882218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of inflammatory responses to radiation and normal tissues toxicity: clinical implications.
    Najafi M; Motevaseli E; Shirazi A; Geraily G; Rezaeyan A; Norouzi F; Rezapoor S; Abdollahi H
    Int J Radiat Biol; 2018 Apr; 94(4):335-356. PubMed ID: 29504497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulation by ionizing radiation-impact for design of radio-immunotherapies and for treatment of inflammatory diseases.
    Frey B; Rückert M; Deloch L; Rühle PF; Derer A; Fietkau R; Gaipl US
    Immunol Rev; 2017 Nov; 280(1):231-248. PubMed ID: 29027224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Myeloid-derived Suppressor Cells and Programmed Death Ligand 1 Confers Therapeutic Advantage of Ablative Hypofractionated Radiation Therapy Compared With Conventional Fractionated Radiation Therapy.
    Lan J; Li R; Yin LM; Deng L; Gui J; Chen BQ; Zhou L; Meng MB; Huang QR; Mo XM; Wei YQ; Lu B; Dicker A; Xue JX; Lu Y
    Int J Radiat Oncol Biol Phys; 2018 May; 101(1):74-87. PubMed ID: 29619980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.